Skip to main content

IM Cannabis Corp(IMCC-CN)
CSE

Today's Change
Delayed Last Update

IMC Announces the Conclusion of the Planning and Construction Legal Proceedings

Newswire.ca - Tue Jan 2, 6:00AM CST

TORONTO and GLIL YAM, Israel, Jan. 2, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the construction proceedings against Focus Medical Herbs Ltd. ("Focus Medical"), were concluded on December 28, 2023. The company maintains "de facto" control of Focus Medical. Focus Medical was indicted and a fine of CAD$129,000 has been imposed. The cultivation facility, which was the focus of the proceedings, was closed in June 2022 in alignment with the company's strategic shift towards import and sales. 

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe